RxDoctor Payments Data

Rodney Lovitt, MD

Family Medicine · Petal, MSNPI 1215042635

Payments from drug & device makers

$2,384in general payments, 2019–2025

Across 149 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$350
  • Johnson & Johnson$269
  • Amgen$262
  • Takeda Pharmaceuticals U.S.A., Inc.$175
  • Pfizer$143
  • Lilly USA, LLC$131
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,384 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$154,948
Medicare patients
296
Services billed
2,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$70,646
EliquisApixaban37$33,695
XareltoRivaroxaban41$29,366
MounjaroTirzepatide17$26,028
JardianceEmpagliflozin35$23,119
Tresiba Flextouch U-200Insulin Degludec13$17,261
ShingrixVaricella-Zoster Ge/As01b/Pf33$7,405
Novolog FlexpenInsulin Aspart14$6,012
MyrbetriqMirabegron11$4,564
SynthroidLevothyroxine Sodium94$4,463
Gabapentin362$3,779
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,670
Atorvastatin Calcium382$2,809
Losartan Potassium228$2,574
Pantoprazole Sodium268$2,327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$350$70,64669 claims
PfizerEliquis$143$33,69537 claims
Johnson & JohnsonXarelto$269$29,36641 claims
Lilly USA, LLCMounjaro$131$26,02817 claims
Boehringer IngelheimJardiance$68$23,11935 claims
GSKShingrix$87$7,40533 claims
Astellas Pharma US IncMyrbetriq$107$4,56411 claims
AbbVieSynthroid$128$4,46394 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Petal

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →